Evidence map›Paper›PMID 20182759›Full record

ArticleNeurogenetics2010

Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.

Margaret Daniele Fallin, Megan Szymanski, Ruihua Wang, Adrian Gherman, Susan S Bassett, Dimitrios Avramopoulos

Abstract read
In one paragraph

Article in Neurogenetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2014
    Article
  7. Article
  8. Article
  9. Evaluating de novo locus-disease discoveries in GWAS using the signal-to-noise ratio.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2011
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Margaret Daniele FallinDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Megan Szymanski
Ruihua Wang
Adrian Gherman
Susan S Bassett
Dimitrios Avramopoulos
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
AN NCRR CENTER FOR HIGH THROUGHPUT SNP GENOTYPING AND ANALYSIS: GAIN NETWORKU54RR020278 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2004 to 2008
$14.4M
DISEASE GENE IDENTIFICATION IN FAMILIAL LATE-ONSET ALZHEIMER'S DISEASER01AG021804 · NIA · JOHNS HOPKINS UNIVERSITY · PI BASSETT, SUSAN SPEAR · 2003 to 2007
$2.9M
Gene detection in regions linked to Alzheimer's diseaseR01AG022099 · NIA · JOHNS HOPKINS UNIVERSITY · PI AVRAMOPOULOS, DIMITRIOS · 2005 to 2009
$1.9M
NCRR NIH HHS U54 RR020278NCRR NIH HHS U54 RR020278-01NIA NIH HHS R01 AG021804NIA NIH HHS R01AG021804NIA NIH HHS R01 AG022099NIA NIH HHS R01AG022099NIA NIH HHS U24 AG021886NIA NIH HHS U24 AG21886NINDS NIH HHS NS077550
6 · The paper itself

Abstract

We have previously reported strong linkage on chromosome 10q in pedigrees transmitting Alzheimer's disease through the mother, overlapping with many significant linkage reports including the largest reported study. Here, we report the most comprehensive fine mapping of this region to date. In a sample of 638 late-onset Alzheimer's disease (LOAD) cases and controls including 104 maternal LOAD cases, we genotyped 3,884 single nucleotide polymorphisms (SNPs) covering 15.2 Mb. We then used imputations and publicly available data to generate an extended dataset including 4,329 SNPs for 1,209 AD cases and 839 controls in the same region. Further, we screened eight genes in this region for rare alleles in 283 individuals by nucleotide sequencing, and we tested for possible monoallelic expression as it might underlie our maternal parent of origin linkage. We excluded the possibility of multiple rare coding risk variants for these genes and monoallelic expression when we could test for it. One SNP, rs10824310 in the PRKG1 gene, showed study-wide significant association without a parent of origin effect, but the effect size estimate is not of sufficient magnitude to explain the linkage, and no association is observed in an independent genome-wide association studies (GWAS) report. Further, no causative variants were identified though sequencing. Analysis of cases with maternal disease origin pointed to a few regions of interest that included the genes PRKG1 and PCDH15 and an intergenic interval of 200 Kb. It is likely that non-transcribed rare variants or other mechanisms involving these genomic regions underlie the observed linkage and parent of origin effect. Acquiring additional support and clarifying the mechanisms of such involvement is important for AD and other complex disorder genetics research.

Indexed as

Genetic LinkageGenetic Predisposition to DiseaseAgedAlzheimer DiseaseCadherin Related ProteinsCadherinsChromosome MappingChromosomes, Human, Pair 10FemaleGenetic LociHumansMalePolymorphism, Single NucleotideCadherin Related ProteinsCadherinsCDHR15, human

Identifiers

PMID20182759
PMCPMC2891147
OpenAlexW2007071024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.